Ionis Pharmaceuticals IONS Less than 12 months
Less than 12 months at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's less than 12 months.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's less than 12 months?
- Ionis Pharmaceuticals (IONS) reported less than 12 months of $1.02B in Q1 2026.
- How has Ionis Pharmaceuticals's less than 12 months changed year-over-year?
- Ionis Pharmaceuticals's less than 12 months increased by 30.4% year-over-year, from $783.82M to $1.02B.